Coastal Spine & Pain Institute, PLLC
Coastal Spine & Pain Institute, PLLC was paid $36K by Medicaid between Oct 2018 and Nov 2024, across 12 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 100% of everything it billed.
BEAUMONT, TX 77701
Next to other Specialist providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 863 | $0.00 | |
| 2019 | 2,746 | $0.00 | |
| 2020 | 803 | $0.00 | |
| 2021 | 2,012 | $11K | |
| 2022 | 1,546 | $11K | |
| 2023 | 1,658 | $8K | |
| 2024incomplete | 1,174 | $5K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 100% | 7,273 | 6,672 | $36K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,214 | 2,001 | $52.58 |
| 99484 | <1% | 209 | 208 | $29.81 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 260 | 240 | $15.57 |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 29 | 29 | $2.20 |
| 99443 | 0% | 219 | 217 | $0.00 | |
| 99406 | 0% | 14 | 14 | $0.00 | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 0% | 23 | 20 | $0.00 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 67 | 66 | $0.00 |
| 99401 | 0% | 241 | 229 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 197 | 195 | $0.00 |
| 99152 | 0% | 56 | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.